Icon

EXFORGE HCT (nda022314)- (EQ 5MG BASE;12.5MG;160MG,EQ 5MG BASE;25MG;160MG,EQ 10MG BASE;12.5MG;160MG,EQ 10MG BASE;25MG;160MG,EQ 10MG BASE;25MG;320MG)

AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; VALSARTAN NOVARTIS
EQ 5MG BASE;12.5MG;160MG,EQ 5MG BASE;25MG;160MG,EQ 10MG BASE;12.5MG;160MG,EQ 10MG BASE;25MG;160MG,EQ 10MG BASE;25MG;320MG
Yes Yes
2023-Nov-16 Expired
None None
None No
Exforge HCT is a combination tablet of amlodipine, a dihydropyridine calcium channel blocker (DHP CCB), valsartan, an angiotensin II receptor blocker (ARB), and hydrochlorothiazide, a thiazide diuretic. Exforge HCT is indicated for the treatment of hypertension to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes, and myocardial infarctions.
3 0 3
Total Other Developers 5
Drugs with Suitability No
EQ 5MG BASE;12.5MG;160MG ** ** - - 2
EQ 5MG BASE;25MG;160MG ** ** - - 2
EQ 10MG BASE;12.5MG;160MG ** ** - - 2
EQ 10MG BASE;25MG;160MG ** ** - - 2
EQ 10MG BASE;25MG;320MG ** ** Up - 2
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ***** *** ***** ******* *********** **** **. **-*, ***** *-*, ***** ********** ****, *****, ********, *** ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.